Related Experiment Videos
Hematologic neoplasia and the central nervous system
R L Sham1, P D Phatak, P A Kouides
1Hematology Unit, Department of Medicine, Rochester General Hospital, Rochester, New York 14621, USA. rsham@rghnet.edu
American Journal of Hematology
|December 10, 1999
Summary
Central nervous system involvement is a known complication of hematologic neoplasms. This series details three rare cases of CNS involvement in myelomatous meningitis, CNS chloromas with acute myeloid leukemia, and primary lymphomatous meningitis.
Area of Science:
- Neurology
- Hematology
- Oncology
Background:
- Central nervous system (CNS) involvement by malignant cells is a recognized complication of hematologic neoplasms.
- While certain hematologic malignancies like acute lymphoblastic leukemia and high-grade lymphoma frequently involve the CNS, others such as acute myeloid leukemia (AML) and multiple myeloma are less commonly associated with CNS disease.
Observation:
- This case series describes three distinct instances of CNS involvement by hematologic malignancies.
- The cases presented include myelomatous meningitis, CNS chloromas complicating AML, and primary lymphomatous meningitis.
Findings:
- The study highlights the occurrence of CNS involvement in hematologic diseases, even in those typically considered lower risk.
- Specific findings detail the clinical presentation and pathological confirmation of these rare CNS manifestations.
Implications:
- These cases underscore the importance of considering CNS involvement in the diagnostic workup of patients with hematologic neoplasms, regardless of the typical risk profile.
- Recognizing these rare presentations is crucial for timely diagnosis and appropriate management of CNS complications in hematologic malignancies.